Latest Breaking News On - குறுக்கு மாசுபாடு - Page 2 : comparemela.com
Gleichstellung von Geimpften, Getesteten und Genesenen fix
orf.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orf.at Daily Mail and Mail on Sunday newspapers.
ÖVP überzeugt: Bis Sommer weitere Lockerungen
heute.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heute.at Daily Mail and Mail on Sunday newspapers.
Peruanas ocupan primeros puestos en ranking de patentes de Indecopi
tvperu.gob.pe - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tvperu.gob.pe Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Single-use Bioprocessing Market Report
The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026.
The outbreak of the COVID-19 pandemic has boosted the demand for single-use bioprocessing (SUB) technology. The ongoing robust R&D activities and clinical studies on the Covid-19 vaccine are encouraging many stakeholders to use SUB technology. Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth. The majority of biomanufacturing companies rely on advanced technology such as single-use systems to develop the vaccine.t.
Single-Use Bioprocessing Market Size to Reach Revenues of over USD 12 Billion by 2026 - Arizton
CHICAGO, March 17, 2021 /PRNewswire/ In-depth analysis and data-driven insights on the impact of COVID-19 included in this global single-use bioprocessing market report.
The single-use bioprocessing market is expected to grow at a CAGR of approximately 17% during the period 2019-2025.
Key Highlights Offered in the Report:
The shift of the biopharmaceutical industry from traditional stainless-steel bioprocessing equipment to single-use ones is majorly influenced by proven economic and operational benefits of SUB technology. As the drive towards personalized medicine and targeted therapies for treating a broad range of chronic and rare diseases continues, biopharmaceutical manufacturers are increasingly using SUTs to produce a large number of products in the same facilities with more changeovers.